Takanobu Matsuzaki, Ph.D.

Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan, Japan

Disclosure(s): Shionogi & Co., Ltd.: Employee

Poster(s):

• 1131 - Evaluation of drug-drug interaction potential of ensitrelvir for CYP3A by clinical studies and physiologically-based pharmacokinetic model
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1136 - No Change of Pharmacokinetics of Metformin by Concomitant Use of Ensitrelvir
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET